# Tumor-Informed cfDNA MRD Pipeline Implementation Plan

## Executive Summary

This document outlines the comprehensive implementation plan for building a Tumor-Informed cfDNA MRD Pipeline to detect Minimal Residual Disease in colorectal cancer patients. The pipeline integrates multiple data modalities including variants, methylation, and fragmentomics to provide accurate MRD detection with ultra-low VAF sensitivity.

## Project Scope

### Dataset
- **90 Stage II/III CRC patients** with matched tumor/WBC exome sequencing
- **50 healthy controls** for baseline establishment
- **Longitudinal plasma cfDNA samples** (t0-t4) with UMI barcoding
- **Multi-modal analysis**: variants, methylation, and fragmentomics

### Objectives
1. **Ultra-low VAF variant caller** with context-aware error suppression and UMI consensus
2. **Multi-modal classifier** integrating variant, methylation, and fragmentomics features
3. **Comprehensive validation** benchmarking LoD, sensitivity/specificity, and longitudinal precision
4. **Production platform** with Nextflow + Docker on AWS infrastructure

## Implementation Phases

### Phase 1: Core Infrastructure (Weeks 1-4)

#### Week 1: Environment Setup
- [ ] **Docker container development**
  - Base Ubuntu 20.04 image
  - Install all required tools (BWA, Samtools, GATK, UMI-tools, etc.)
  - Python environment with scientific packages
  - Test container functionality

- [ ] **Nextflow workflow framework**
  - Set up main workflow structure
  - Configure AWS Batch executor
  - Implement input/output channel management
  - Test workflow execution

#### Week 2: Data Preprocessing Module
- [ ] **UMI-aware preprocessing pipeline**
  - UMI extraction and tagging
  - Quality trimming with fastp
  - BWA-MEM alignment
  - UMI-aware deduplication
  - Quality control metrics

- [ ] **WES preprocessing**
  - Tumor and normal sample processing
  - Base quality score recalibration
  - Coverage analysis
  - Quality metrics generation

#### Week 3: Variant Calling Infrastructure
- [ ] **Tumor-informed somatic variant detection**
  - GATK Mutect2 implementation
  - Panel of normals integration
  - Germline resource filtering
  - High-confidence truth set generation

- [ ] **Ultra-low VAF detection**
  - Context-aware error suppression
  - Statistical filtering algorithms
  - Quality score calibration

#### Week 4: Quality Control & Validation
- [ ] **Automated QC modules**
  - Coverage statistics
  - Quality metrics aggregation
  - Sample-level QC reports
  - Pipeline monitoring

### Phase 2: Feature Extraction (Weeks 5-8)

#### Week 5: Variant Feature Extraction
- [ ] **Truth set variant analysis**
  - VAF calculation at truth set loci
  - Variant burden metrics
  - Allele frequency distributions
  - Coverage depth analysis

- [ ] **UMI consensus calling**
  - Threshold-based consensus
  - Error rate estimation
  - Confidence scoring

#### Week 6: Fragmentomics Analysis
- [ ] **DNA fragment size analysis**
  - Size distribution histograms
  - End motif analysis
  - Nucleosome positioning inference
  - Fragment quality metrics

- [ ] **TSS proximity features**
  - Transcription start site analysis
  - Promoter region coverage
  - Gene expression correlation

#### Week 7: Methylation Analysis
- [ ] **DMR panel analysis**
  - Differentially methylated region detection
  - Methylation level quantification
  - CpG island analysis
  - Methylation-based features

- [ ] **Reference methylome comparison**
  - Healthy control baseline
  - Disease-specific patterns
  - Longitudinal methylation changes

#### Week 8: Feature Integration
- [ ] **Multi-modal feature matrix**
  - Feature normalization
  - Missing data handling
  - Feature correlation analysis
  - Dimensionality reduction

### Phase 3: MRD Classification (Weeks 9-12)

#### Week 9: Machine Learning Framework
- [ ] **Classifier development**
  - Random Forest implementation
  - Feature selection algorithms
  - Hyperparameter optimization
  - Cross-validation strategies

- [ ] **Model training**
  - Training data preparation
  - Model training pipeline
  - Performance evaluation
  - Model selection

#### Week 10: Threshold Calibration
- [ ] **Clinical threshold determination**
  - ROC curve analysis
  - Precision-recall optimization
  - Clinical decision point selection
  - Threshold validation

- [ ] **Confidence scoring**
  - Uncertainty quantification
  - Confidence interval calculation
  - Risk stratification

#### Week 11: Model Validation
- [ ] **Performance metrics**
  - Sensitivity/specificity analysis
  - ROC AUC calculation
  - Precision-recall curves
  - F1-score optimization

- [ ] **Cross-validation**
  - K-fold cross-validation
  - Leave-one-out validation
  - Bootstrap resampling
  - Performance stability assessment

#### Week 12: Model Deployment
- [ ] **Production model**
  - Final model selection
  - Model serialization
  - API development
  - Integration testing

### Phase 4: Validation & Benchmarking (Weeks 13-16)

#### Week 13: Spike-in Experiments
- [ ] **LoD determination**
  - Known concentration spike-ins
  - Serial dilution series
  - Detection limit calculation
  - Reproducibility assessment

- [ ] **Performance benchmarking**
  - Sensitivity curves
  - Specificity analysis
  - False positive rate estimation

#### Week 14: Reference Standard Validation
- [ ] **External validation**
  - Reference material testing
  - Inter-laboratory comparison
  - Method validation
  - Performance certification

- [ ] **Quality assurance**
  - Quality control procedures
  - Standard operating procedures
  - Documentation standards

#### Week 15: Retrospective Cohort Analysis
- [ ] **Clinical outcome correlation**
  - Disease progression analysis
  - Treatment response correlation
  - Survival analysis
  - Prognostic value assessment

- [ ] **Longitudinal precision**
  - Time-series analysis
  - Consistency metrics
  - Trend analysis
  - Stability assessment

#### Week 16: Performance Benchmarking
- [ ] **Comparative analysis**
  - Alternative method comparison
  - Literature benchmark comparison
  - Performance gap analysis
  - Improvement recommendations

### Phase 5: Production Platform (Weeks 17-20)

#### Week 17: Nextflow Workflow Optimization
- [ ] **Workflow efficiency**
  - Process optimization
  - Resource allocation
  - Parallel execution
  - Error handling

- [ ] **Configuration management**
  - Parameter optimization
  - Resource requirements
  - Performance tuning
  - Scalability testing

#### Week 18: Docker Containerization
- [ ] **Container optimization**
  - Image size reduction
  - Layer optimization
  - Security hardening
  - Registry management

- [ ] **Container testing**
  - Functionality testing
  - Performance testing
  - Compatibility testing
  - Integration testing

#### Week 19: AWS Infrastructure Setup
- [ ] **Cloud infrastructure**
  - AWS Batch configuration
  - EC2 instance types
  - S3 storage setup
  - IAM role configuration

- [ ] **Monitoring and logging**
  - CloudWatch integration
  - Log aggregation
  - Performance monitoring
  - Cost optimization

#### Week 20: Final Integration & Testing
- [ ] **End-to-end testing**
  - Full pipeline execution
  - Performance validation
  - Error handling testing
  - User acceptance testing

- [ ] **Documentation and deployment**
  - User manual creation
  - API documentation
  - Deployment guide
  - Training materials

## Technical Architecture

### Data Flow
```
Raw FASTQ → UMI Processing → Alignment → Variant Calling → Feature Extraction → MRD Classification → Validation → Reporting
```

### Key Components
1. **Preprocessing Module**: UMI extraction, quality control, alignment
2. **Variant Calling Module**: Tumor-informed somatic variant detection
3. **Feature Extraction Module**: Multi-modal feature integration
4. **MRD Classification Module**: Machine learning-based prediction
5. **Validation Module**: Performance benchmarking and validation
6. **Reporting Module**: QC dashboards and comprehensive reports

### Technology Stack
- **Workflow Management**: Nextflow
- **Containerization**: Docker
- **Cloud Platform**: AWS (Batch, EC2, S3)
- **Analysis Tools**: GATK, BWA, Samtools, UMI-tools
- **Machine Learning**: scikit-learn, pandas, numpy
- **Visualization**: matplotlib, seaborn
- **Programming**: Python, Bash

## Risk Assessment & Mitigation

### Technical Risks
- **Data quality issues**: Implement comprehensive QC checks
- **Algorithm performance**: Extensive validation and benchmarking
- **Scalability challenges**: Cloud-native architecture with auto-scaling

### Operational Risks
- **Resource constraints**: AWS auto-scaling and resource optimization
- **Timeline delays**: Agile development with regular milestones
- **Quality issues**: Automated testing and validation pipelines

### Mitigation Strategies
- **Phased approach**: Incremental development with regular testing
- **Parallel development**: Multiple modules developed simultaneously
- **Continuous validation**: Ongoing performance monitoring and validation
- **Expert consultation**: Regular review with domain experts

## Success Metrics

### Technical Metrics
- **Sensitivity**: >90% for MRD detection
- **Specificity**: >95% for healthy controls
- **LoD**: <0.1% VAF detection capability
- **Processing time**: <24 hours for full cohort

### Operational Metrics
- **Pipeline reliability**: >99% success rate
- **Resource efficiency**: Optimal AWS resource utilization
- **User satisfaction**: Intuitive interface and comprehensive reporting

## Resource Requirements

### Human Resources
- **Bioinformatics Engineer**: Full-time (20 weeks)
- **Data Scientist**: Full-time (12 weeks)
- **DevOps Engineer**: Part-time (8 weeks)
- **Domain Expert**: Part-time consultation (ongoing)

### Infrastructure
- **AWS Cloud Services**: Batch, EC2, S3, CloudWatch
- **Development Environment**: Local development setup
- **Testing Environment**: Staging environment for validation

### Software Licenses
- **Open Source**: GATK, BWA, Samtools, UMI-tools
- **Commercial**: AWS services, development tools

## Deliverables

### Phase 1 Deliverables
- Docker container with all tools
- Nextflow workflow framework
- Preprocessing pipeline
- Variant calling infrastructure

### Phase 2 Deliverables
- Feature extraction pipeline
- Multi-modal feature matrix
- Quality control reports

### Phase 3 Deliverables
- MRD classification model
- Calibrated thresholds
- Performance validation results

### Phase 4 Deliverables
- Validation benchmarks
- Performance metrics
- Clinical correlation analysis

### Phase 5 Deliverables
- Production-ready pipeline
- AWS infrastructure
- Comprehensive documentation
- User training materials

## Timeline Summary

| Phase | Duration | Key Milestones |
|-------|----------|----------------|
| 1 | Weeks 1-4 | Core infrastructure, preprocessing, variant calling |
| 2 | Weeks 5-8 | Feature extraction, multi-modal integration |
| 3 | Weeks 9-12 | MRD classification, model development |
| 4 | Weeks 13-16 | Validation, benchmarking, clinical correlation |
| 5 | Weeks 17-20 | Production platform, deployment, documentation |

## Next Steps

1. **Immediate Actions**
   - Set up development environment
   - Begin Docker container development
   - Start Nextflow workflow framework

2. **Week 1 Goals**
   - Complete environment setup
   - Begin preprocessing module development
   - Establish testing framework

3. **Success Criteria**
   - Functional preprocessing pipeline
   - Working variant calling module
   - Initial feature extraction capabilities

This implementation plan provides a comprehensive roadmap for building a production-ready Tumor-Informed cfDNA MRD Pipeline. The phased approach ensures systematic development with regular validation and testing, ultimately delivering a robust and clinically relevant tool for MRD detection in colorectal cancer patients.
